|
KMID : 0378119860130010222
|
|
Chungnam Medical Journal
1986 Volume.13 No. 1 p.222 ~ p.226
|
|
|
The Study on the Therapeutic Effect of Rimactan(Rifamycin) against E. histolytica
|
|
|
|
|
Abstract
|
|
|
Rimactan (Rifamycine) is one of the most effective drugs for the treatment of tuberculosis and also shows promise in the treatment of certain nonmycobacterial diseases.
A total 20 cases of E. histolytica cyst excretion patients were treated with Rimactan 10 mg per body weight divided two for 20 days.
All cases (20) showed negative convertion of E. histolytica cyst in the feces 7 days after beginning drug administration. 14 days and 20 days after beginning drug administration 17 cases (85%) out of 20 cases showed negative convertion of E. histolytica cyst, and 16 cases(80%) out of 20 cases were cured clinically and parasitologically 27 days after beginning drug administration (7 days after stopping drug administration).
The tolerance of this drug was good, and side effects were noted mild and transient.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|